news
Wednesday, May 16 2012

MIVAC Development has decided to no longer pursue the project for the development of a new vaccine against gastric ulcer and gastric cancer.

Read more...
 
Tuesday, December 20 2011

MIVAC Development creates a new company, Toleranzia AB, for the spin-out of the tolerance inducing Re-TolerogenTM platform.

Read more...
 
Thursday, November 24 2011

MIVAC development receives continued financial support from Innovationskontor Väst for the tolerance inducing Re-TolerogenTM platform.

 
Wednesday, August 17 2011

MIVAC Development creates a new company, Alzinova AB, for the spin-out of the AβCCTM-project.

Read more...
 
Wednesday, June 01 2011

Synthon and MIVAC Development enter into exclusive research collaboration and commercial licensing agreement in multiple sclerosis.

Read more...
 
Monday, April 11 2011

MIVAC Development announces an opening in the area of molecular biology to strengthen the team working on our tolerance-inducing technology platform.

Read more...
 
Wednesday, February 02 2011

MIVAC Development receives verification grants from Innovationskontor Väst for both the AβCCTM-project and for the tolerance inducing Re-TolerogenTM platform.

Read more...
 
Monday, January 03 2011

MIVAC Development receives verification grant from GöteborgBIO and Sahlgrenska Science Park (SSP).

Read more...
 
Friday, September 03 2010

The AβCCTM invention receives attention on the Alzheimer Research Forum webpage.

Read more...
 
Monday, August 16 2010

MIVAC researchers publishes data on covalently stabilized amyloid-β aggregates.

Read more...
 
Wednesday, June 23 2010
MIVAC Development develops a new promising vaccine against gastric ulcer and gastric cancer.

Read more...
 
Monday, May 18 2009

New board members strengthen MIVAC Development’s expertise in commercial pharmaceutical operations and include a voice for the scientists at the MIVAC research center.

Read more...
 
Monday, May 18 2009
MIVAC Development held General Assembly & Celebrated our new localities.
 
Tuesday, May 12 2009
A letter of intent was filed with BioInvent regarding the AD-project.
 
Tuesday, May 05 2009
The Swedish Patent and Registration Office approved the MIVAC trademark.
 
Tuesday, April 14 2009
PCT-application was filed for the AD-project to the Swedish Patent and Registration Office.
 
Tuesday, April 07 2009
Swedish Foundation for Strategic Research (SSF) granted the research center MIVAC an additional 6 MSEK.
 
Monday, March 30 2009
Vinnova funded the verification process in the Tolerance project over a two year period.
 
Tuesday, March 24 2009
MIVAC Development AB Annual report.
 
Tuesday, March 24 2009
MIVAC Development’s Annual report was presented.
 
Tuesday, February 10 2009
The Holding company at University of Gothenburg (GUH) decided to invest in MIVAC Development.
 
Friday, December 19 2008
Sahlgrenska Science Park (SSP) funded the Tolerance project to develop a protein production process.
 
Friday, December 12 2008
MIVAC Development received funding from Innovationsbron for business developmental activities in the AD-project.
 
Tuesday, December 09 2008
PCT-application was filed for the Tolerance project to the Swedish Patent and Registration Office.
 
Saturday, November 01 2008
MIVAC Development moved into the Biotech center at Arvid Wallgrens backe 20, Gothenburg, and bought laboratory equipment from Biovitrum.
 
Thursday, October 16 2008
An MTA agreement was signed with Affibody regarding the AD-project.
 
Tuesday, September 16 2008
Västra Götalandsregionen (VGR) granted the research center MIVAC 1 MSEK.
 
Wednesday, September 03 2008
MIVAC Development bought the IPR rights for the AD-project.
 
Thursday, August 28 2008
MIVAC Development bought the IPR rights for the Tolerance project.
 
Monday, June 16 2008
MIVAC Development was formed!
 
Saturday, February 09 2008
PCT-application is filed in the Tolerance project.